These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 7211388)

  • 1. [The effects of infusion rate of Changrolin on drug concentration in blood and ECG (author's transl)].
    Qu ZX; Cao CY; Zhuang YH
    Yao Xue Xue Bao; 1980 Aug; 15(8):449-55. PubMed ID: 7211388
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular effect of a new antiarrhythmic drug--changrolin (author's transl)].
    Chen WZ; Dong YL; Ding GS
    Yao Xue Xue Bao; 1979 Dec; 14(12):710-4. PubMed ID: 554432
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiarrhythmic effect of 4-(3',5'-bis ((n-pyrrolidinyl) methyl)-4'-hydroxyanilino) quinazoline (changrolin) on aconitine-induced arrhythmia in rats (author's transl)].
    Wang ZM; Zhang YF; Ding GS
    Yao Xue Xue Bao; 1979 Jul; 14(7):408-11. PubMed ID: 532636
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on a new antiarrhythmic drug changrolin-4-(3',5'-bis [(N-pyrrolidinyl) methyl]-4'-hydroxyanilino)-quinazoline.
    Li LQ; Qu ZX; Wang ZM; Zeng YL; Ding GS; Hu GJ; Yang XY
    Sci Sin; 1979 Oct; 22(10):1220-8. PubMed ID: 515728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical pharmacokinetics of pyromecaine. Prolonged intravenous infusion and the relation between its antiarrhythmic effect and its concentration].
    Piotrovskiĭ VK; Blagodatskikh SV; Metelitsa VI; Smirnov VK; Gorshkov VA
    Farmakol Toksikol; 1985; 48(4):83-6. PubMed ID: 2412887
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of antiarrhythmic drug changrolin on myocardial contractility in anesthetized dogs (author's transl)].
    Shen YT; Wu PM; Wan FT; Chen WZ; Dong YL
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):23-6. PubMed ID: 6461194
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic analysis of changrolin in dogs with arrhythmia.
    Liu CX; Gu YB; Feng JL; Wei GL; Xiao SH; Sun JL
    Yao Xue Xue Bao; 1996; 31(9):666-70. PubMed ID: 9863232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of denudatine on experimental arrhythmia and heart function (author's transl)].
    Jin LS; Zhou YP; Zeng GY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):104-8. PubMed ID: 6214142
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intracellular distribution of changrolin (author's transl)].
    Tu ZH; Chen EH; Wu WW; Yang HH
    Yao Xue Xue Bao; 1979; 14(10):594-7. PubMed ID: 539425
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of antiarrhythmic effects of intravenous injections of changrolin and BL-4712A(author's transl)].
    Wang CG; Wang ZM; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1982 Mar; 3(1):29-31. PubMed ID: 6211899
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-arrhythmic effect of changrolin combined with nicotinamide in experimental arrhythmia].
    Gu CG; Chen WZ; Dong YL; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Sep; 5(3):173-7. PubMed ID: 6239508
    [No Abstract]   [Full Text] [Related]  

  • 12. [Physiological disposition of changrolin (author's transl)].
    Zeng YL; Yi QC; Gu HM; Qu ZX; Xu GY
    Zhongguo Yao Li Xue Bao; 1981 Sep; 2(3):177-81. PubMed ID: 6462008
    [No Abstract]   [Full Text] [Related]  

  • 13. [Plasma drug concentration and cardiac function in arrhythmic patients during continuous drip of changrolin].
    Xu JM; Yin XL; Chen YM; Qi HM; Li CF; Shen LY; Chen WZ; Wang CG
    Zhongguo Yao Li Xue Bao; 1987 May; 8(3):227-31. PubMed ID: 2959017
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on drugs for coronary diseases. II. Synthesis of compounds related to changrolin as potential antiarrhythmic drugs (author's transl)].
    Sun CJ; Zhang XY; Yang XZ; Wang PP; Shen J; Shu Y; Ji RY
    Yao Xue Xue Bao; 1981 Aug; 16(8):564-70. PubMed ID: 7324955
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effects of Ca++ antagonistic drug, verapamil, on heart rate, arterial blood pressure, ECG, and blood catecholamine concentration during neuroleptanesthesia (author's transl)].
    Nishimoto T; Shibata O; Haseba S; Goto Y; Hagiwara M
    Masui; 1981 Dec; 30(12):1310-6. PubMed ID: 7346646
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical pharmacokinetics of the anti-arrhythmic agent changrolin].
    Chen WZ; Wang CG; Yang XY; Cai NS; Zhu JR
    Yao Xue Xue Bao; 1985 Jul; 20(7):505-8. PubMed ID: 4096242
    [No Abstract]   [Full Text] [Related]  

  • 17. Liquid chromatography/tandem mass spectrometry for the determination of changrolin in rat plasma: application to a bioavailability study.
    Yang D; Yu C; Li S; Liu G; Lu Y; Wang Y
    J Pharm Biomed Anal; 2009 Sep; 50(2):189-93. PubMed ID: 19467818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pharmacodynamics of bucainide (RHC G233): pharmacokinetic parameters and relationship between plasma levels and the effect on the electrocardiogram in the dog.
    Grebow P; Feeney W; Johnston M; Lettieri J; Li H; Magnien E; O'Brien P; Swillo R; Weinryb I; Wolf P; Marsiglia JC
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):407-21. PubMed ID: 7268191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of intravenous infusion of massive dose of cephalothin on the respiration, blood pressure, electrocardiogram and urine excretion of dogs (author's transl)].
    Takeda H; Matsumura S; Uno M; Ueda M
    Jpn J Antibiot; 1975 Apr; 28(2):343-8. PubMed ID: 1152281
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of levosimendan during long-term amiodarone treatment in dogs.
    Papp JG; Pollesello P; Varró A; Végh A; Udvary E
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):27-32. PubMed ID: 16867167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.